Article PDF
Rights and permissions
About this article
Cite this article
Corcoran, C. Telor Ophthalmic is second quarter's sole IPO. Nat Biotechnol 11, 982 (1993). https://doi.org/10.1038/nbt0993-982a
Issue Date:
DOI: https://doi.org/10.1038/nbt0993-982a